secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0001213900-25-004220
Event type: regulatory
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix reverts to foreign private issuer SEC filing status effective Jan 1, 2025
--------------------------------------------------------------------------------

- Company determined it qualifies as FPI as of Dec 31, 2024; will cease domestic issuer filings.
- Effective Jan 1, 2025, Renalytix will file periodic reports using FPI forms.
- Company had previously been an FPI but filed as domestic since July 1, 2023.
- Change may reduce SEC reporting burden (e.g., no quarterly 10-Q, different GAAP allowed).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000121390025004220/0001213900-25-004220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000121390025004220/ea0227953-8k_renalytix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-004220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer